Amana healthcare first in UAE to earn U.S. accreditation as stroke specialty center

▴ Amana healthcare
Up to 90% of stroke sufferers do not get the help they need owing to poor awareness of existence and importance of rehabilitation services.

Abu Dhabi residents and their families now have access to a new world-class standard of stroke rehabilitation care, the first of its level in the UAE.

Amana Healthcare, part of Mubadala’s network of healthcare providers, was recently awarded Stroke Specialty Center accreditation by the U.S. Commission on Accreditation of Rehabilitation Facilities (CARF). The commission is an international, non-profit organization founded in 1966 to assist and assess healthcare providers with a particular focus on post-acute services such as inpatient rehabilitation.

With this new specialty accreditation, Amana, which was the first in the UAE to receive accreditation in Comprehensive Intensive Inpatient Rehabilitation from CARF in 2016, becomes the first and only provider in the country to be specifically accredited in rehabilitation after stroke, fulfilling a key part of its mandate to provide the people of the nation with healthcare of the highest global standard.


Eng. Abdulla Abdulaziz Al Shamsi, Head of Mubadala Healthcare, said: “This new accreditation confirms Amana Healthcare’s status as a truly world-class provider of post-acute rehabilitation and a vital player in the UAE healthcare ecosystem. It is a source of pride to Mubadala and of hope to people with complex rehabilitation needs – especially the 10,000 or more people who suffer a stroke each year in the UAE.”

Stroke is a leading cause of disability in the UAE and strikes at a much younger age here compared with cases in Europe or North America. The average age of a stroke patient in the UAE is 48 years old; in the UK and US, by contrast, it is over 60.

Stroke rehabilitation is the process of regaining functions that are lost when a part of the brain is damaged by a stroke. The chances of recovery increase dramatically with the implementation of an effective, multidisciplinary rehabilitation program. However, according to Amana Healthcare, as many as 90% of stroke sufferers do not get the help they need, often because of poor awareness of the existence and importance of rehabilitation services.

At Amana, rehabilitation experts create specialized treatment plans to meet each patient’s individual needs. Advanced rehabilitation helps them regain their physical, sensory, intellectual and psychological functions, reduce activity limitations, maximize quality of life and prevent recurrence.

Amana’s highly personalized approach – and its team of over 750 rehabilitation professionals from all disciplines including physical medicine, physiotherapy, occupational therapy and speech therapy, among others – means patients have a better outlook and a greater chance of successful recovery.

Dr. Khalid Anwar, a consultant in physical medicine and rehabilitation at Amana Healthcare, said: “Amana was built on a vision of providing the highest standard of care possible. Building on our Comprehensive Intensive Inpatient Rehabilitation Program accreditation, the new Stroke Specialty Center certification makes it clear that stroke sufferers who seek care at Amana will benefit from a standard of rehabilitation not found anywhere else in the UAE.”

Amana Healthcare, acquired by Mubadala in early 2019, operates medical and rehabilitation hospitals in the UAE, where it provides a comprehensive range of post-acute services including long-term care, post-acute rehabilitation and specialized home healthcare.

Tags : #amana #uscertification #strokespecialitycenter #medicircle

Related Stories

18 Jun

FDA approves nasal antihistamine for nonprescription use

Seasonal allergies affect millions causing nasal congestion, runny nose and sneezing. Approval of Asteopro (Azelastine Hydrochloride nasal spray 0.15%) can help many patients with allergies.

View
23 Dec

Glenmark collaborates with Menarini for commercializing Ryaltris nasal spray across Europe

The licensing agreement will be effective in 33 countries throughout the European region including France, Italy, and Spain

View
18 Dec

Research on preventative nasal spray, which protects against COVID-19 and common cold, published in leading peer-reviewed academic journals

Research on a novel nasal spray therapy, INNA-051, which has been shown to reduce COVID-19 viral replication by up to 96 percent in a gold standard ferret study, has been published in two leading international peer-reviewed journals.

View
07 Oct

Glenmark Pharmaceuticals receives ANDA approval for Dimethyl Fumarate Delayed-Release Capsules

Glenmark Pharmaceuticals Inc., USA has been granted final approval by the U.S. FDA for Dimethyl Fumarate DR Capsules, the generic version of Tecfidera

View
18 Aug

Glenmark appoints Dipankar Bhattacharjee to its Board of Directors

Glenmark Pharmaceuticals announced the appointment of Mr Dipankar Bhattacharjee as Independent Non-Executive Director on the Board of the organization

View
30 Jul

Food Allergies: All that you have to know

Skin prick testing can in some cases produce bogus negative or bogus positive outcomes.

View
21 May

Cipla receives final approval for Migranal

Cipla receives final approval for generic version of Migranal (Dihydroergotamine Mesylate Nasal Spray) with a Competitive Generic Therapy Designation

View
12 May

Hikma Announces the Launch of Propofol Injectable Emulsion, USP

Hikma responds to COVID-19 shortage with launch of Propofol Injectable Emulsion, USP. Sedative for patients on ventilators currently in short supply in the US

View
28 Feb

Glenmark Pharma Signs an Exclusive Licensing Agreement with Hikma Pharmaceuticals

Under the terms of the agreement, Glenmark will be responsible for the continued development and regulatory approval of Ryaltrisâ„¢ by the US FDA, while Hikma will be responsible for the commercialization of Ryaltrisâ„¢ in the US.

View

-Advertisements-




Trending Now

The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025
High-Rise Heart Attacks: Are Skyscrapers Turning Survival into a Race Against Time?April 02, 2025
DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?April 02, 2025
Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025